Clifford Chance
Healthcare & Life Sciences Update: The Netherlands
1 November 2016
The legal landscape for companies active in the Dutch healthcare and life sciences sector continues to change. This Healthcare & Life Sciences Update sets out some of the latest regulatory developments which may impact your business: the new circular regarding pharmacy-to-pharmacy supply, the amendment of the rules on disclosure of financial relationships and the increase of the maximum fine for culpable medicines shortage.
